This page lists feature articles on COVID-19 relevant to people working at St Vincent's Health Australia.
All articles listed are open access unless stated otherwise.
Therapy
Health outcomes 3 months and 6 months after molnupiravir treatment for COVID-19 for people at higher risk in the community (PANORAMIC): a randomised controlled trial.
Lancet Infectious Diseases:2024: September 9 Full text
SARS-CoV-2 antivirals and post-COVID-19 condition.
Lancet Infectious Diseases:2024: September 9 Full text
Lower mortality risk associated with remdesivir + dexamethasone versus dexamethasone alone for the treatment of patients hospitalized for COVID-19.
Clinical Infectious Diseases:2024: September 20 Full text
Clinical Practice
Lower or higher oxygenation targets in ICU patients with COVID-19 – a secondary Bayesian analysis of the HOT-COVID trial.
Chest:2024: September 18 Full text
Dose–response relationship between awake prone-positioning duration and PaO2/FiO2 changes and risk of disease aggravation in patients with severe COVID-19: A prospective cohort study. AUS
Australian Critical Care:2024: September 10 Full text
Infection Control
Consistent FFP2-masking as part of reducing viral respiratory infections on medical wards for allogeneic hematopoietic stem cell transplantation.
Scientific Reports:2024: September 14 Full text
Attitudes and behaviours regarding COVID-19 mitigation strategies in Australians with an underlying health condition: a cross-sectional study. AUS
Health Expectations:2024: September 12 Full text
Pathophysiology
Post-hospitalisation COVID-19 cognitive deficits at one year are global and associated with elevated brain injury markers and grey matter volume reduction.
Nature Medicine:2024: September 23 Full text
Changes in memory and cognition during the SARS-CoV-2 human challenge study.
eClinicalMedicine:2024:September 21 Full text
Fibrin drives thromboinflammation and neuropathology in COVID-19.
Nature:2024: August 28 Full text
Long COVID
Characteristics and predictors of Long Covid in children: a 3-year prospective cohort study.
eClinicalMedicine:2024: September 5 Full text
Impact of COVID-19 on myalgic encephalomyelitis/chronic fatigue syndrome-like illness prevalence: A cross-sectional survey.
PLOS One:2024: September 17 Full text
Vaccines
An intranasally administered adenovirus-vectored SARS-CoV-2 vaccine induces robust mucosal secretory IgA.
JCI Insight:2024: September 24 Full text
COVID-19 and mental illnesses in vaccinated and unvaccinated people.
JAMA Psychiatry:2024: August 21 Full text
Immunology
Molecular mechanisms of thalidomide effectiveness on COVID-19 patients explained: ACE2 is a new ΔNp63α target gene.
Journal of Molecular Medicine:2024: September 18 Full text
SARS-CoV-2-specific CD8+ T cells from people with long COVID establish and maintain effector phenotype and key TCR signatures over 2 years.
PNAS:2024: September 16 Full text
Heterogeneity of SARS-CoV-2 immune responses after the nationwide Omicron wave in China.
Microbiology Spectrum:2024: September 17 Full text
